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In Thailand, traditional plant-based medicines have always 
been used to treat gastrointestinal ailments, including 
gastritis, peptic ulcer disease (PUD) and diarrhea. Since 
Helicobacter pylori (HP) is an etiological agent of PUD, 
we have used an ethnomedical approach for screening 
plant extracts as potential treatments for HP infections, 
including over 20 species from Thailand. International 
Memoranda of Agreement were established between UIC 
and Mahidol University in Thailand. Medicinal plants were 
collected, identified and extracted. Susceptibility testing 
was performed with 15 HP strains using the agar dilution 
procedure guidelines of the Clinical and Laboratory Stan-
dards Institute. In vivo studies included evaluating bacte-
rial load, as well as acute and chronic inflammation in HP-
infected Mongolian gerbils. Extracts of Curcuma longa 
L. and Boesenbergia rotunda (L.) Mansf. significantly re-
duced HP-induced gastric lesions, as assessed both mac-
roscopically and microscopically in Mongolian gerbils. The 
treatments reduced acute and/or chronic inflammation in 
a prevention model of HP-induced gastritis. 
Introduction
Although the incidence and mortality of gastric cancer has 
declined in industrialized nations, it still remains the sec-
ond leading cause of cancer deaths worldwide, particu-
larly in Southeast Asia (Jemal et al. 2002, Kneller et al. 
1992). Globally, as many as 1 million people die each year 
of gastric cancer (Anon 2006). Gastric cancer evolves 
through a multi-step mechanism in which the Gram-nega-
tive bacterium Helicobacter pylori (HP) plays a major role 
(IARC 1994). 
Helicobacter pylori (HP) is a spiral or helical-shaped aero-
bic bacillus that colonizes the gastric epithelial surface, 
and can withstand the stomach’s environment by micro-
aerophilic growth capability and high urease activity (For-
man & Graham 2004). Chronic HP infections are associ-
ated with the development numerous gastrointestinal dis-
orders, including dyspepsia, duodenal and gastric ulcer-
ation, gastric cancer, and mucosa-associated lymphoid 
tissue (MALT) lymphoma (Breuer-Katschinski et al. 1999, 
Figueriredo et al. 2002, Forman et al. 2004). In 1994, the 
International Agency for Research on Cancer classified 
HP as a human carcinogen, and a definite cause of gas-
tric cancer (IARC 1994). 
According to statistics from the World Health Organiza-
tion, approximately 50% of the population in industrial-
ized nations, and 80% of the populations in developing 
countries infected with HP (Perez-Perez et al. 1990). In 
Thailand, the incidence of HP infection is similar to other 
countries in Southeast Asia, with HP antibodies present 
in approximately 17.5% of children ages 5-9 years, but 
increasing to 75% in the 30- to 49-year-old group (Maha-
chai et al. 2000). However, although there is a high preva-
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lence of HP infection in Thailand, the incidence of gastric 
atrophic changes, intestinal metaplasia, and gastric can-
cer are significantly lower than other countries (Atisook et 
al. 2003, Matsuhisa et al. 2003, Sriamporn et al. 2002). 
The reasons for this paradox are not well understood but 
appear to be related to diet and life style (Bhamarapravati 
et al. 2003). The diet in Thailand includes a wide range of 
unique fruits, vegetables and spices, many of which are 
also used ethnomedically for the treatment of gastrointes-
tinal disorders (Murakami et al. 1994).  
Ethnobotanical searches and reviews Traditional Thai 
medical texts, as well as the Napralert database for plants 
used in Thailand for the treatment of gastrointestinal and 
HP infections, led to a list of over 50 plant species, of 
which 20 (as 25 plant parts) were collected in Thailand for 
testing. The plant parts were extracted and the extracts 
tested for anti-HP activity in vitro, of which 12 extracts 
were shown to be active in vitro (13). Here, we report new 
in vitro and in vivo data on two Thai plants from the Zingib-
eraceae, namely finger-root (Boesenbergia rotunda (L.) 
Mansf.) and turmeric (Curcuma longa L.), both of which 
are used in Thailand for the treatment of gastrointestinal 
ailments, including peptic ulcer disease (Mahady 2005). 
Materials and Methods
Reviews of Traditional Thai medical texts and the Napralert 
database for plants used in Thailand for the treatment of 
gastrointestinal and HP infections were performed as de-
scribed (Bhamarapravati et al. 2003). These searches led 
to a list of over 50 plant species from Thailand, of which 
the results of 20 were previously reported (Bhamarapra-
vati et al. 2003)(Figure 1). Two plant species were select-
ed for further in vitro and in vivo testing: Boesenbergia 
rotunda (finger-root) and Cucurma longa (turmeric) based 
on their use in Traditional Thai medicine for the treatment 
of gastrointestinal ailments.
The rhizomes of these plants were collected in Thailand 
after obtaining a Memorandum of Agreement between the 
University of Illinois at Chicago and Mahidol University, 
Bangkok, Thailand. Five hundred grams of finger-root rhi-
Figure 1. Results of 25 Thai plant 
samples tested against Helicobacter 
pylori.
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zomes and 1 kg of dried turmeric rhizomes were obtained 
from Jatujak market, Jatujak, Bangkok, Thailand. The 
collected plants were identified by Ms. Thaya Jenjittikul, 
Department of Plant Science, Faculty of Science, Mahi-
dol University, Bangkok, Thailand. Herbarium specimens 
were deposited at Mahidol University, Faculty of Science. 
The outer surface of the rhizomes were cleaned with soap 
and water, the plant parts were cut into 1 cm slices and 
then dried in 550C hot air oven for 24-48 h. The dried rhi-
zomes were then ground to a fine powder and extracted 
twice in an Erlenmeyer flask containing 95% ethanol (2 x 
500 ml) at room temperature on a rotary shaker for 24 h. 
Each extract was filtered through Whatman no. 1 filter pa-
per and the resultant filtrate was concentrated to dryness 
under reduced pressure. The extracts were then defatted 
with 500 ml of hexane and the resulting defatted extracts 
were concentrated to dryness under reduced pressure. 
The concentrated extracts were stored in coded sterile bo-
rosilicate glass vials under desiccation at -20ºC. A 10.0 mg 
sample of each plant extract was used for the in vitro sus-
ceptibility testing against the various HP strains. For the 
animal studies, 100 grams of the extracts were prepared.
In Vitro susceptibility Testing
Susceptibility testing was performed using the agar dilu-
tion procedure guidelines of The National Committee for 
Clinical Laboratory Standards (NCCLS 2005). The plant 
extract were dissolved using a minimal volume of solvent. 
The solvents used to dissolve the extracts were dimethyl 
sulfoxide (DMSO), ethanol, or sterile distilled water. Ster-
ile distilled water was used for further dilutions (serial) of 
the dissolved plant extracts. Final concentrations of the 
extracts tested included 100, 50, 25, and 12.5 µg/ml for 
each sample. The in vitro HP susceptibility tests were per-
formed exactly as previously described (Bhamarapravati 
et al. 2003, Mahady et al. 2003a,b). A total of five cagA+ 
strains of HP were tested, rodent adapted strain B128, 
M23-3, GTD7-13, G1-1, SS1 and the American Type Cul-
ture Collection (ATCC) (Rockville, MD) strain (#43504) of 
HP were used in the susceptibility testing. Clinical isolates 
were obtained from Dr. Rick Peek, Division of Gastroen-
terology, Vanderbilt University, Nashville, TN. The identi-
fication of each organism has been confirmed by Gram 
stain appearance and a positive urease test. Staphylococ-
cus aureus ATCC 29213 was included in the susceptibility 
testing of the plant extracts and amoxicillin for validation 
of results. 
An inoculum of each isolate was prepared by suspending 
the organism in 4.5 ml of sterile tryptic soy broth and ad-
justing the turbidity to that of a 2.0 McFarland Standard us-
ing a spectrophotometer at 625 nm. This density produces 
a suspension of approximately 1 x 106 CFU/ml of HP. The 
organisms were inoculated onto agar plates containing the 
plant extracts via a 32-prong inoculating device. The de-
vice delivers 8 µl per spot resulting in a final inoculum of 
approximately 1 x 104 CFU/spot. After the spots dried, the 
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plates were incubated at 370C in 10% CO2 and examined 
for growth after 5 days. All procedures were performed 
in duplicate. The minimum inhibitory concentration (MIC) 
was determined for each plant extract. The MIC is defined 
as the lowest concentration of an extract or compound at 
which there is no visible growth (Mahady et al. 2003). To 
ensure that the vehicle did not affect HP growth, minimal 
to maximal volumes of vehicle solvent were also tested. 
For quality control and comparative analysis, the antibiot-
ics amoxicillin and metronidazole were also tested with 
each batch of plant extracts, as a positive control. For the 
animal studies, the cagA+ HP strain B128 was maintained 
as previously described (Israel et al. 2001).
Mongolian gerbil model
Specific pathogen-free male Mongolian gerbils (Charles 
River, Wilmington, Massachusetts, USA), 6 weeks old, 
were housed in an air-conditioned biohazard room with 
a 12 h light-dark cycle, and were fed a commercial diet 
(PURINA 5100) and water ad libitum for 24 hours. The 
animals were handled according to the guidelines of the 
AAC and the protocols for this study were approved by the 
Institutional Animal Care Committee, at the University of 
Illinois at Chicago prior to the initiation of the work. 
In the four-armed study, group A (n = 10) negative control 
group and did not receive the treatment or HP challenge. 
Group B (n =10) served as a positive control and received 
the HP-challenge but no treatment. Both groups A and B 
received a standard diet chow (Purina 5100). Groups C 
and D were the treatment groups and were fed the same 
chow supplemented with the plant extracts (100 mg/kg 
body weight) for 3 weeks prior to challenge with HP, and 
then 6 more weeks after challenge. At 9-weeks of age, all 
animals except Group A (10 negative controls) were fasted 
for 12 h and then inoculated with the rodent-adapted HP 
cag+ strain B128 by gavage (0.5 ml, 1.7 × 106 CFU/ani-
mal). Negative control animals were given sterilized broth 
alone (n = 10). After inoculation, each animal was fasted 
for 4 h and then fed a basal diet or basal diet supplement-
ed with turmeric extract or finger root extract (dose calcu-
lated at 100 mg/kg body weight/day for six weeks). Body 
weights, as well as diet and water intake were measured 
three times a week, respectively, and animals were moni-
tored daily for their general health.
Six weeks post-infection, all animals were sacrificed un-
der CO2 euthanasia and their stomachs were resected, 
opened along the greater curvature, and washed twice 
with saline. The macroscopic gastric lesions (edema and 
hemorrhage) in the glandular stomach were recorded, 
and the wet weight of the whole stomach was measured. 
The glandular stomach was divided into halves, and one 
half was fixed in 10% neutral buffered formalin for histo-
logical examination, and the other half was transferred to 
1.0 ml of sterile 0.1 M phosphate buffered saline (PBS, 
pH 7.4), homogenized, and plated on selective Trypticase 
soy agar/5% sheep blood plates containing vancomycin 
(20 ug/ml), nalidixic acid (10 µg/ml), bacitracin (30 µg/ml), 
and amphotericin B (2 µg/ml) (Sigma Chemical Company, 
St. Louis, MO) and grown for 3 to 5 days, as previously 
described (19). After 5 days, the colonies were counted 
to determine the level of HP colonization of each stom-
ach. Colonies were identified as HP based on their char-
acteristic morphology, and by urease and oxidase activi-
ties; colony counts were expressed as log CFU per stom-
ach. Colonization density was determined by quantitative 
culture and acute inflammation and chronic inflammation 
(mononuclear cell infiltration independent from lymphoid 
follicles) were each graded from 0-3 in the gastric antrum, 
as previously described (Israel et al. 2001; Table 1).
Statistical analyses
An unpaired t test or a Mann-Whitney U test was applied 
to determine the differences in quantitative data for gastric 
lesions and HP infection between two groups. P values of 
<0.05 were considered to be statistically significant. 
Results
  
Thai medicinal plants for gastrointestinal ailments
Searches of the ethnomedical Thai literature and the 
Napralert database resulted in a list of over 50 plant spe-
cies used in Thailand for the treatment of gastrointestinal 
ailments. Prioritization of the 50 plant species for collec-
tion and testing purposes was performed by associating 
each of the plant species with previously published ex-
perimental reports of antibacterial, anti-ulcer, anti-inflam-
matory and anti-oxidant activities. This resulting prioritiza-
tion led to a list of 25 plants that were top priority for test-
Table 1. Grading criteria for chronic inflammation and activity of gastritis
Grade Chronic inflammation Activity
0 No increase in number of inflammatory cells Same
1 Uniform infiltration of lamina propria by lymphocytes, 
plasma cells, and some eosinophils
Scattered neutrophils in the lamina propria with no 
leukopedesis in the region of the gastric pits
2 Moderately dense infiltration of the lamina propria 
by lymphocytes and plasma cells
Moderate number of neutrophils in the lamina propria 
with microabscess in the region of gastric pits
3 Very dense lymphoplasma cell infiltration in the 
lamina propria
Extensive neutrophils in the lamina propria with 
obvious cryptitis. 
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Table 3. Minimum inhibitory concentrations of 95% ethanol extracts of Boesenbergia rotunda and Curcuma longa 
rhizomes in 6 CagA+ strains of Helicobacter pylori. Data are the result of three experiments in triplicate.
Thai plant extracts Minimum Inhibitory Concentration (MIC µg/ml) CagA+ HP strains
M23-3 GTD7-13 G1-1 SS1 ATCC 43504 B128
Boesenbergia rotunda 3.125 3.125 3.125 3.125 3.125 3.125
Curcuma longa 6.25 12.5 12.5 6.25 6.25 6.25
ing (Table 2). Twenty-one of these plants were previously 
tested in vitro (Bhamarapravati et al. 2003). Here, we re-
port that two additional species on the priority list, name-
ly Boesenbergia rotunda and Curcurma longa, were also 
found to be active both in vitro and in vivo, bringing the hit 
rate to 56% thereby validating this ethnomedical screen-
ing approach (Figure 1). 
In vitro susceptibility
The ethanol extracts of Thai turmeric and finger-root rhi-
zomes inhibited the growth of all 6 CagA+ strains of HP 
in vitro. The MIC ranges for both finger-root and turmeric 
were 3.125 – 6.25 μg/ml (Table 3). Thus, these two plants 
were very active in vitro, and ranked in the top 10% of all 
Thai plants tested (Figure 1). 
Effects in Mongolian gerbils
In this work, we investigated whether the treatment of HP-
infected Mongolian gerbils with finger-root or turmeric ex-
tracts reduced bacterial load, as well as acute and chronic 
inflammatory responses to HP infection. Administration 




Table 2. Top priority plant samples that were tested.
Plant taxa sampled Thai name Parts sampled (source)
Artemisia vulgaris L. (Asteraceae)                leaf1
Barringtonia acutangula (L.) Gaertn. (Lecythidaceae)          leaf1
Boesenbergia rotunda (L.) Mansf. (Zingiberaceae)             rhizome
Bridelia ovata Decne. (Euphorbiaceae)         leaf1
Cassia grandis L.f. (Fabaceae)          leaf1
Cleome viscosa L. (Capparaceae)                leaf4 & stem4
Curcuma longa L. (Zingiberaceae)             rhizome
Cycas siamensis Miq. (Cycadaceae)                    spongy integument2 
& sarcotesta2
Dioscorea hispida Dennst. var. hispida (Dioscoreaceae) aerial tuberous stem1
Kaempferia galanga L. (Zingiberaceae) rhizome2
Litsea elliptica Blume (Lauraceae)         leaf1
Melaleuca quinquenervia (Cav.) S.T. Blake (Myrtaceae)        leaf6
Moringa oleifera Lam. (Moringaceae)         bark3
Myristica fragrans Houtt. (Myristicaceae)               aril1
Myristica sp. (Myristicaceae)              aril1
Persicaria chinensis (L.) H. Gross. (Polygonaceae)                 leaf5 & aril5
Piper retrofractum Vahl (Piperaceae)        leaf1
Pouzolzia pentandra (Roxb.) Benn. (Urticaceae)                       leaf4
Syzygium aromaticum (L.) Merr. & L.M. Perry (Myrtaceae)            leaf1
Zingiber officinale Roscoe (Zingiberaceae)     rhizome
1One Hundred Year Herbal Garden, Ministry of Public Health, Makham, Chantaburi, Thailand, February 2001.
2Jatujak market, Jatujak, Bangkok, Thailand, February, 2001.
3Author’s garden, Bangkhen, Bangkok, Thailand, February 2001.
4Siri Rukachard Herbal Garden, Mahidol University, Salaya, Nakornpathom, Thailand, February 2001.  
5Salaya, Nakornpathom, Thailand, February 2001.
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weeks, at a dose of 100 mg/kg bw, did not adversely affect 
food intake or body weights of the gerbils. The results of 
this experiment are shown in Table 4. In Group A, no HP 
was be detected, nor was any inflammation observed. In 
Group B, 80% of animals inoculated with HP were infect-
ed and developed severe gastritis with edema and hem-
orrhage in the antrum. Microscopic erosion with infiltration 
was observed with marked infiltration of inflammatory cells 
in the lamina propria and submucosa. This infiltration was 
predominantly polymorphonuclear leukocytes and lym-
phocytes, although some macrophages and neutrophils 
were also observed. Gastric changes were also severe in 
the pyloric region, but moderate in the fundic region. The 
average microscopic score for gastritis of the HP-inoculat-
ed control animals (Group B) was 2.5, while in the nega-
tive control animals (Group A), the average microscopic 
score was 0 (Table 4). The average stomach weight of 
control gerbils inoculated with HP was approximately 1.5-
fold of that for animals without inoculation. 
Treatment with the finger-root extract for 9 weeks signifi-
cantly reduced HP load in challenged Mongolian gerbils 
as compared with Group B (p < 0.05; Figure 2). The pa-
rameters of HP-induced acute and chronic inflammation 
were also significantly (p < 0.05) decreased in Group C 
as compared with the HP-challenged untreated Group B. 
(Table 4). Both chronic (mean: 2.5 vs. 1.0; control vs. ex-
tract, respectively) and acute mucosal (mean: 2.2 vs. 0.7; 
control vs. extract, respectively, p < 0.05) inflammation 
scores, as well as acute and chronic submucosal inflam-
matory parameters (mean: 1.8 vs. 0.3 and 1.5 vs. 0.1 con-
trol vs. extract respectively, p < 0.01) were decreased in 
gerbils treated with the finger-root extract. These changes 
were paralleled by significant reductions in the severity of 
epithelial cell degeneration (2.0 control vs. 0.3 extract, p < 
0.05), cryptitis (1.1 control vs. 0.25 extract, p < 0.05) and 
erosions (2.0 control vs. 0.2 extract, p < 0.01). Thus, treat-
ment significantly reduced both acute and chronic mus-
cosal and submucosal inflammation, cryptitis, as well as 
epithelial cell degeneration and erosion induced by HP in-
fection (Table 4). Importantly, the extract did not increase 
morbidity or mortality of the animals. 
Table 4. Reduction in acute and chronic inflammatory parameters, erosion and cryptitis induced by Helicobacter pyrlori 





Erosion Cryptitis Chronic Inflammation Acute Inflammation
Mucosal Submucosal Mucosal Submucosal
A (10) 0 0 0 0 0 0 0
B (10) 2.0 2.0 1.1 2.5 1.8 2.2 1.5
C (10) 0.3** 0.2** 0.25** 1.0* 0.3** 0.7* 0.1*
D (10) 1.5 1.0* 0.5* 1.2* 0.8* 2.0 0.9
Group A: no treatment and no Helicobacter pylori challenge.
Group B: Helicobacter pylori challenge but no treatment.
Group C: Helicobacter pylori challenge treated with finger-root extract.
Group D: Helicobacter pylori challenge treated with turmeric extract.
* P < 0.05 ** P < 0.01



















Figure 2. Reduction in bacterial load per treatment group. 
Group A, Monogolian gerbils were not challenged with HP; 
Group B, Mongolian gerbils challenged with HP but received 
no treatment; Group C, Mongolian gerbils challenged with 
HP but received treatment of 100 mg/kg b.w. of finger-root 
extract (p < 0.05); Group D, Mongolian gerbils challenged 
with HP and received treatment of turmeric extract (100 
mg/kg b.w.)
Treatment with the turmeric extract (Group D) did not sig-
nificantly reduce bacterial load or acute inflammatory pa-
rameters as compared with group B, but did significantly 
(p < 0.05) reduce HP-induced chronic mucosal and sub-
mucosal inflammation, cryptits, and erosion. Chronic mu-
cosal (mean: 2.5 vs. 1.2; control vs. extract, respectively, p 
< 0.05) and submucosal inflammatory parameters (mean: 
1.8 vs. 0.8, control vs. extract respectively, p < 0.05) were 
decreased in gerbils treated with turmeric (Table 4).
Discussion
Thailand has long incorporated the use of food and spice 
plants into everyday medical practice. This custom was in-
troduced to Thailand with Buddhism 700-1000 years ago 
(Bunyapraphatsara 1990). While the practice was inter-
rupted during the wars in Thailand in the mid-eighteenth 
century, King Rama III later revived it again, in 1821 (Bu-
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nyapraphatsara 1990). Hundreds of stone plaques in-
scribed with knowledge of all kinds including medical 
texts, were established at Wat Photharaam, an old temple 
built during the Ayuthaya period. Royal medical texts were 
complied in 1871 by a committee of medical doctors ap-
pointed by King Rama V were revised and published, and 
are the basis for Thai traditional medicine practice today 
(Bunyapraphatsara 1990). This ethnomedical approach to 
healthcare is currently promoted by the Thai government, 
through the Ministry of Health. Thus, unlike the West, eth-
nomedicine in Thailand is not an alternative, but is actually 
integrated into standard medical care, as for many people 
in Thailand become the mainstay of pharmacotherapy.
Curcuma longa (turmeric) has been used in Thailand for 
hundreds of years for the treatment of peptic ulcer dis-
ease (Mahady et al. 2002). Curcumin (Figure 3), one of 
the polyphenolic chemical constituents derived from tur-
meric rhizomes has been shown to prevent gastric and co-
lon cancers in rodents. Many mechanisms have been pro-
posed for the chemopreventative effects, however here 
we demonstrate that turmeric inhibits the chronic inflam-
matory responses to HP infection, as well as erosion and 
cryptitis in vivo. Interestingly, the chemical structure of the 
curcurmin is similar to that of the gingerols from Zingiber 
officinale (ginger), that are also very active against HP in-
fections (Figure 2; Mahady et al. 2003a). 
The second plant species tested in this work, Boesenber-
gia rotunda (L.) Mansf. (Zingiberaceae, finger-root) was 
also very active both in vitro and in vivo. Finger-root is 
used frequently in Thai cooking as a culinary spice, as 
well as ethnomedically to treat gastrointestinal ailments 
and oral diseases. In this investigation, finger-root extracts 











                                                R1           R2
Curcurmin                           -OCH3     -OCH3
Desmethoxycurcumin         -OCH3        -H
Bisdesmethoxycurcurmin      -H            -H
Figure 3. Structures of the gingerols, the anti-HP 
constituents of ginger (Zingiber officinale) and the 
curcumins, the active constituents of turmeric (Curcuma 
longa).
response to HP challenge in the Mongolian gerbil model. 
The HP strain used for this investigation was B128, a cag+ 
strain of HP. CagA is the strain-specific HP gene that is 
linked to the development of premalignant and malignant 
histological lesions, and thus infections caused by cagA+ 
strains significantly increase the risk for developing severe 
gastric inflammation, atrophic gastritis and noncardia gas-
tric adenocarcinoma (Censini et al. 1996). Loss or inacti-
vation of the entire cag locus profoundly attenuates the se-
verity of gastritis and development of atrophy in Mongolian 
gerbils infected with H. pylori (Magari et al. 2005). Thus, 
cag+ strains induce more inflammation than cag- strains 
and chronic inflammation is thought to play a central role 
in the accumulation of genetic events leading to transfor-
mation and cancer by increasing the number of target cells 
or by promoting the proliferation of initiated cells. (Magari 
et al. 2005). 
Conclusions
Our investigations have demonstrated that the ethnomedi-
cal use of specific Thai plants for the treatment of gastro-
intestinal disorders have a plausible mechanism of action 
in that they inhibit the growth of HP in vitro and in vivo. 
In fact, using an ethnomedical approach to screen for in-
hibitors of HP, led to a 56% hit rate, of which 78% of the 
plant extracts were very active with a an MIC of < 50 μg/ml 
in vitro. More importantly, in experiments with Mongolian 
gerbils, finger-root significantly reduced bacterial load, and 
both finger-root and turmeric treatments significantly re-
duced the acute and chronic inflammatory response to HP 
infections. These data suggest that not only can these Thai 
plants be used for the prevention and treatment of HP in-
fections and they may also be chemopreventative against 
gastric cancer, which may explain the lower incidence of 
gastric cancer in Thailand.
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